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The gene Disrupted-In-Schizophrenia-1 (DISC1) has been indicated as a determinant of psychopathology,
including affective disorders, and shown to inﬂuence prefrontal cortex (PFC) and hippocampus func-
tioning, regions of major interest for affective disorders. We aimed to investigate whether DISC1
differentially modulates brain function during executive and memory processing, and morphology in
regions relevant for depression and anxiety disorders (affective disorders). 128 participants, with
(n ¼ 103) and without (controls; n ¼ 25) affective disorders underwent genotyping for Ser704Cys (with
Cys-allele considered as risk-allele) and structural and functional (f) Magnetic Resonance Imaging (MRI)
during visuospatial planning and emotional episodic memory tasks. For both voxel-based morphometry
and fMRI analyses, we investigated the effect of genotype in controls and explored genotypeXdiagnosis
interactions. Results are reported at p < 0.05 FWE small volume corrected. In controls, Cys-carriers
showed smaller bilateral (para)hippocampal volumes compared with Ser-homozygotes, and lower
activation in the anterior cingulate cortex (ACC) and dorsolateral PFC during visuospatial planning. In
anxiety patients, Cys-carriers showed larger (para)hippocampal volumes and more ACC activation during
visuospatial planning. In depressive patients, no effect of genotype was observed and overall, no effect of
genotype on episodic memory processing was detected. We demonstrated that Ser704Cys-genotype
inﬂuences (para)hippocampal structure and functioning the dorsal PFC during executive planning,
most prominently in unaffected controls. Results suggest that presence of psychopathology moderates
Ser704Cys effects.
© 2014 Elsevier Ltd. All rights reserved.iversity Medical Center Gro-
The Netherlands. Tel.: þ31 50
pmeer), m.j.van.tol@umcg.nl
s), n.j.van_der_wee@lumc.nl
dstra), m.van_buchem@lumc.
nninx), dj.veltman@vumc.nl1. Introduction
The gene Disrupted-In-Schizophrenia-1 (DISC1) has been iden-
tiﬁed in a linkage-study as a risk for several psychiatric disorders
(Millar et al., 2000; Blackwood et al., 2001). This gene codes for a
protein important for neural growth and synaptic modulation
(Morris et al., 2003; Kamiya et al., 2006) and the single nucleotide
polymorphisms (SNP) Ser704Cys has shown to inﬂuence glia-cell
functioning (Eastwood et al., 2010). The Cys-allele of this poly-
morphism has been associated with depression (Hashimoto et al.,
E.M. Opmeer et al. / Journal of Psychiatric Research 61 (2015) 150e157 1512006), although genome wide associations failed to show this as-
sociation with the depression phenotype (Sullivan et al., 2009;
Wray et al., 2012). Nevertheless, genetic variations have shown to
be potent in explaining variance on an endophenotypical neuro-
biological level, an approach thatmight increase our understanding
of the complex linkage of genes and the phenotype of affective
disorders, including depression and frequent comorbid anxiety
disorders.
DISC1-expression is highest in hippocampal regions and pre-
frontal cortex (PFC) (Porteous et al., 2006; Chubb et al., 2008), re-
gions that have been linkedwith impairments in affective disorders
during memory (Milne et al., 2011; Fairhall et al., 2010; Werner
et al., 2009; Van Tol et al., 2012) and executive functioning
(Fitzgerald et al., 2008; Goethals et al., 2005; Van Tol et al., 2011).
Therefore, altered hippocampal and PFC function during these
processes could serve as promising endophenotypes in studying the
association between DISC1-genotype and affective disorders. Sup-
portive of this suggestion, in healthy people, the Cys-allele of the
Ser704Cys SNP has been associated with less hippocampal activa-
tion during working memory (WM) and more hippocampal acti-
vation during episodic memory (Callicott et al., 2005), and with less
activation of the dorsolateral prefrontal cortex (DLPFC) during both
memory (Di Giorgio et al., 2008) and executive functioning (Prata
et al., 2008). Moreover, smaller hippocampus (Di Giorgio et al.,
2008) and anterior cingulate cortex (ACC) volume (Hashimoto
et al., 2006) have been demonstrated in Cys-carriers, whereas
larger DLPFC volume has been observed (Brauns et al., 2011;
Takahashi et al., 2009). These observations suggest that DISC1-
genotype is involved in functioning and structure of hippocampal,
ACC and prefrontal regions. However, these associations have been
found in separate studies. It has to our knowledge not yet been
investigated whether these associations could be replicated within
one and the same sample. In addition, whether similar associations
are present in patients with affective disorders has not been studied
to date.
The primary aim of this study was to investigate the effects of
Ser704Cys-genotype on function and structure of the ACC, DLPFC
and hippocampus in a single sample showing no psychopathology.
We hypothesized that Cys-carriers will show smaller grey matter
(GM) volumes and less activation during tasks of spatial WM and
episodic memory in these regions. Furthermore, we aimed to
explore whether similar associations were present in patients with
depression and/or anxiety disorders.
2. Materials and methods
2.1. Participants
Participants were recruited from the large-scale longitudinal
multi-site Netherlands Study of Depression and Anxiety (NESDA
(Penninx et al., 2008)). The ethical review boards of each partici-
pating center (University Medical Center Groningen [UMCG], VU
Medical Center [VUMC], and Leiden University Medical Center
[LUMC]) gave approval for this study. The study was conducted in
accordance with the declaration of Helsinki. All participants pro-
vided written informed consent.
Exclusion criteria for all participants for the MRI study were 1)
presence or history of a neurological or somatic disorder with
possible effects on the central nervous system, 2) general MRI
contraindications, 3) dependence or recent abuse (past year) of
alcohol or drugs, 4) hypertension and 5) use of other psychotropic
medication than SSRIs or infrequent use of benzodiazepines
(oxazepam or diazepam, maximum of three times a week and not
within 48 h before scanning). An additional exclusion criterion for
the control groupwas a history of any DSM-IV axis-I disorder basedon the Composite International Diagnostic Interview (CIDI) e life-
time version 2 (Robins et al., 1988). We included all genotyped
participants who completed the full MRI-scanning protocol
without technical problems and with sufﬁcient task performance
(see for criteria (Van Tol et al., 2012; Van Tol et al., 2011)). Diagnoses
were deﬁned based on half-year diagnosis assessed using the CIDI.
We included in total 128 participants: 25 controls, 38 depressed
patients (MDD), 28 anxiety patients (panic disorder (PD), social
anxiety disorder (SAD) and/or generalized anxiety disorder (GAD);
ANX) and 37 patients with comorbid depression-anxiety (CAD).
Groups were matched on age, education, and sex. All participants
were Caucasian and unrelated to each other.
2.2. Clinical variables
Diagnosis was conﬁrmed with the Composite International
Diagnostic Interview (CIDI)e lifetime version 2 (Robins et al., 1988).
To assess depression and anxiety symptom severity at moment of
scanning, the Montgomery-Asberg Depression Rating Scale
(MADRS) (Montgomery and Asberg, 1979) and the Beck Anxiety
Inventory (BAI) (Beck et al., 1988) was assessed. These measures
have good psychometric properties (Beck et al., 1988; Carmody
et al., 2006; Bernstein et al., 2010).
2.3. Genotyping
Genotyping was performed in the context of the genome wide
association (GWA) study of the Genetic Association Information
Network (GAIN) (Sullivan et al., 2009). Perlegen Sciences
(Mountain View, CA, USA) performed all genotyping according to
standard operating procedures. High-density oligonucleotide
arrays were used yielding 599,164 SNPs. These arrays included
the SNP rs821616 (Ser704Cys), a T to A base substitution, leading
to a serine to cysteine substitution. All groups were in Har-
dyeWeinberg equilibrium (HWE, [Cys/Cys:Cys/Ser:Ser/Ser] con-
trols 0:14:11 [c2(1) ¼ 3.78, p ¼ 0.05], MDD 1:19:18 [c2(1) ¼ 2.38,
p¼0.12], CAD 3:20:14 [c2(1) ¼ 0.26, p ¼ 0.26], ANX 2:14:12
[c2(1) ¼ 0.60, p ¼ 0.44]). Groups did not differ in genotype dis-
tribution (c2(6) ¼ 3.36, p ¼ 0.76). We compared Cys-carriers
(Cys/Cys- and Cys/Ser-genotypes) with Ser-homozygotes, based
on the small amount of Cys-homozygotes and in agreement with
the literature (Hashimoto et al., 2006; Callicott et al., 2005; Di
Giorgio et al., 2008; Prata et al., 2008; Brauns et al., 2011;
Takahashi et al., 2009).
2.4. Image acquisition parameters
All participants were scanned using a Philips 3T MR-scanner
located at each site. A SENSE-8 channel head coil was used for ra-
dio frequency transmission and reception in Groningen and Leiden.
In Amsterdam, a SENSE-6 channel head coil was used. For each
subject, a series of echo planar imaging (EPI) volumes were ob-
tained, entailing a T2*weighted gradient echo sequence using axial
whole brain acquisition, with an interleaved slice acquisition order
and with the following settings for Groningen: repetition time
(TR) ¼ 2300 ms; echo time (TE) ¼ 28.0 ms; ﬂip angle of 90; 39
slices per EPI volume; matrix size: 64  64; in-plane resolution of
3  3 mm; slice thickness 3 mm and no gap. In Amsterdam and
Leiden the following settingswere used: TE 30 ms; 35 slices; matrix
size: 96  96 voxels; in-plane resolution: 2.29  2.29 mm slice
thickness. All images were acquired parallel to the ante-
rioreposterior commissure plane. In addition, a T1-weighted
anatomical MRI was made (TR ¼ 9 ms, TE ¼ 3.5 ms, matrix size
256  256, voxel size: 1  1  1 mm, 170 slices).
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2.5.1. Memory processing
The task (for a full description see (Van Tol et al., 2012; Daselaar
et al., 2003)) consisted of an implicit word encoding- and recogni-
tion phase. During the encoding phase, participants were asked to
classify negative, positive and neutral words (40 each) according to
their valence (button press). In addition, 40 baseline trials were pre-
sented, which consisted of the words “left”, “middle” or “right” (in
Dutch), indicating which button to press. Words were presented
pseudo-randomized.
After a retention interval of ten minutes during which the T1-
weighted anatomical scan was made, old encoding target words
(120), new distracter words (120; matched on valence) and 40
baselines were presented pseudo-randomized and participants had
to indicate whether they had seen the words previously, probably
had seen it, or had not seen it before.
The task was self-paced, but with a maximum presentation
duration of ﬁve seconds.2.5.2. Spatial working memory
TheTowerofLondon(ToL) task involvesvisuospatialplanningwith
varying levels of difﬁculty that relies on the fronto-parietal executive
system (Welsh et al.,1999). The taskwasdesignedasdescribedbyVan
Tol et al. (2011); Van den Heuvel et al. (2003). On the screen two
pictures were shown with colored balls on rods, representing two
conﬁgurations, one start and one goal (Fig. 1). In the task condition,
participants had to count the number of steps (ranging from one to
ﬁve) needed to reach the goal conﬁguration. In the control condition,
instructionswere toworkout thenumberofblueandyellowballs.We
used a pseudo-randomized, self-paced design with maximal presen-
tation duration of 60 seconds for each trial.
Accuracyand response times (RTs)were registered forboth tasks.2.6. Statistical analyses
2.6.1. Clinical, demographic and behavioral data
Group effects on clinical, demographic, and behavioral data
were analyzed using SPSS (version 16.0, SPSS Inc., Chicago, IL, USA).
ChieSquare tests and analyses of variance (ANOVA) were used to
analyze group differences.Fig. 1. Tower of London task and genotype effects on response times. A.) On the screen two
starting conﬁguration and one goal conﬁguration. Participants had to count the number of
pseudorandomized, self-paced design with maximal response duration of 60 seconds for
difﬁculty effect was observed on RTs (F(1.7196) ¼ 3.51, p ¼ 0.04): post-hoc tests showed tha
(p ¼ 0.03). Error bars represent one standard error. (For interpretation of the references toFor the memory task, the proportion correct recognitions were
analyzed with repeated-measures ANCOVAwith valence as within-
subject variable and diagnosis and genotype as between-subject
variables. Age and education were entered as covariates of no in-
terest. This was repeated for the RTs during encoding on the sub-
sequently remembered trials and the RTs to correctly recognized
words during recognition.
For the ToL-task, accuracy and RTs were analyzed by means of
separate repeated-measures ANCOVAs, using the proportion cor-
rect scores and mean RTs per trial type as dependent factors, and
psychopathology and genotype as between-subject factors. Age
and education were entered as covariates. For post-hoc contrasts,
we chose a repeated procedure to compare the more difﬁcult step
with one step easier (e.g. step5 vs. step4).
For both the memory and ToL-task we tested for a possible
confounding effect of selective serotonin reuptake inhibitor (SSRI)
use by means of a repeated-measures ANOVA with SSRI-use as
between-subject variable and the behavioral measurement as
within-subject variable. We chose to test for this possible
confounder post-hoc, because of the small number of participants
in some of the groups.2.6.2. Preprocessing and model for structural imaging
Structural data were analyzed using voxel-based morphometry
(VBM), following diffeomorphic anatomical registration through
exponentiated lie algebra (DARTEL (Ashburner. 2007)) using SPM5.
Preprocessing of VBM-DARTEL on these data has been described
previously (Van Tol et al., 2010). Brieﬂy, we applied the DARTEL
approach for registration, normalization, and modulation after
uniﬁed segmentation of the manually reoriented T1-images and
smoothed the resulting grey matter (GM) images using an 8-mm
FWHM Gaussian kernel.
A 2 (genotype) by 4 (diagnosis) ANOVA was built with the total
brain volume (sum of gray and white matter, demeaned for the
group) as covariate of no interest. Voxel-wise comparisons were
masked with an explicit optimal threshold GM-mask created using
the Masking toolbox (Ridgway et al., 2009).2.6.3. Preprocessing and models for functional imaging
Functional imaging data were preprocessed and analyzed using
Statistical Parametric Mapping (SPM5; http://www.ﬁl.ion.ucl.ac.uk/pictures were shown with colored balls on rods, representing two conﬁgurations, one
steps (ranging from one to ﬁve) needed to reach the target conﬁguration. We used a
each trial. Accuracy and response times (RTs) were measured. B.) A genotype by task
t Ser-homozygotes had a larger increase in RT from step 4 to step 5 than Cys-carriers
colour in this ﬁgure legend, the reader is referred to the web version of this article.)
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processing included slice-time correction, realignment, registration
of the T1-scan to the mean EPI, warping to MNI-space as deﬁned by
the T1-template, reslicing to 3  3  3 mm voxels and spatial
smoothing using an 8-mm Full Width at Half Maximum (FWHM)
Gaussian kernel.
Completemodeling details for the memory task are described in
the supplement. Analysis of the encoding phase was restricted to
correctly recognized words in the subsequent recognition phase
(successfully encoded words). Contrasts were made for
‘encoding_positive > encoding_neutral’ and ‘encoding_negative >
encoding_neutral’ Also for the recognition phase analyses were
restricted to correct trials and the contrasts ‘recognition_positive >
recognition_neutral’, and ‘recognition_negative > recognition_
neutral’, were calculated following the summary statistics
approach. On second level, a full-factorial 2 (genotype) by 4
(diagnosis) by 2 (valence, as non-independent factor) ANOVA was
built for the encoding and recognition part separately.
For the ToL-task, regressors were constructed by convolving
each event-related stimulus function (baseline, 1e5 step trials)
with a canonical hemodynamic response function and modulated
using RTs. In addition, error and no-response trials were included
as a regressor of no interest. Contrast images for “task load” (with
trial types 1e5 having weights [1.5 1 0.5 1 2]) were calculated
per subject on a voxel-by-voxel basis (Van Tol et al., 2011). On
second level, a 2 (genotype) by 4 (diagnosis) ANOVA was built.2.6.4. Regions of interest and statistical thresholds
Based on literature (see introduction) regarding executive and
memory function in affective disorders and effects of DISC1 on
neural processing, we selected the following regions of interest
(ROIs): anterior cingulate cortex (ACC; BA 32 and 24), bilateral
DLPFC (BA 9 and 46), and bilateral parahippocampal areas (hip-
pocampus and parahippocampal gyrus [PHG]) based on the auto-
mated anatomical labeling (AAL) atlas (Maldjian et al., 2003)
implemented in the Wake Forest University (WFU) pickatlas
(http://fmri.wfubmc.edu/cms/software). These labels were used to
construct ROIs, which were applied as masks for the small volume
corrections.Table 1
Demographics and clinical variables for Ser704Cys.
A) Divided according to genotype
Ser/Ser
N 55
# Males (%) 19 (34.5)
Age 36.18 (10.10)
Years of education 13.18 (2.70)
Scanning site (VUMC/LUMC/UMCG) 15/24/16
Diagnosis (HC/MMD/MDDþ/ANX) 11/18/14/12
MADRS scores 11.50 (9.21)
BAI scores 9.35 (13.72)
# Medication use (%) 12 (21.8)
B) Divided according to diagnosis
Controls MDD only
N 25 38
# Males (%) 12 (48) 15 (39.5)
Age 39.36 (9.38) 36.63 (9.97)
Years of education 14.12 (2.26) 13.08 (2.84)
Scanning site (VUMC/LUMC/UMCG) 10/10/5 10/13/15
# Cys-allele (%) 14 (56) 20 (52.6)
MADRS scores 0.76 (1.56) 12.22 (8.43)
BAI scores 2.32 (2.93) 5.50 (12.49)
# Medication use (%) e 10 (26.31)
Abbreviations: ANX: anxiety disorder; MDD: Major Depressive Disorder; VUMC: VU M
MADRS: Montgomery-Asberg rating scale; BAI: Beck Anxiety Inventory.For all models, we ﬁrst investigated the effect of genotype in HC,
to investigate the effects of the SNP on the healthy brain. These
effects were reported at p < 0.05, family wise error (FWE) corrected
for the spatial extent of the ROI at the voxel level, with an initial
voxel-wise threshold of Z > 3.09 (equivalent to p < 0.001
uncorrected).
We next explored whether the effects seen in HC were also
present in patients with a threshold of p < 0.05, family wise error
(FWE) corrected for the spatial extent of the ROI at the voxel level,
with an initial voxel-wise threshold of Z > 3.09 (equivalent to
p < 0.001 uncorrected). In addition, we formally tested for the
presence of an interaction between genotype and diagnosis using
an F-test at p < 0.001, uncorrected.
Effects occurring outside of our predeﬁned ROIs had to meet
p < 0.05 FWE whole brain corrected at the voxel level, with an
initial voxel-wise height threshold of Z > 3.09.
The effects of diagnosis in this sample on brain function during
visuospatial planning (Van Tol et al., 2011), episodic memory (Van
Tol et al., 2012) and regional morphometry (Van Tol et al., 2010)
have been reported previously.
To test for the effects of possible confounding variables such as
selective serotonin reuptake inhibitor (SSRI) use, education, age,
sex, scanning center, symptom severity (measured with MADRS
and BAI) and regional volume, the mean voxel signals of signiﬁcant
clusters were calculated using MarsBaR (Brett et al., 2002) and
exported to SPSS. We chose to test for these possible confounders
post-hoc, because of the small number of participants in some of the
groups.3. Results
3.1. Genotype associations on demographic and clinical data
Demographic and clinical data are summarized in Table 1.
Diagnostic groups did not differ on genotype distribution, and no
effect of genotype or diagnosis was observed on any of the de-
mographic variables (all p > 0.05). The diagnostic groups differed
from each other on depression and anxiety severity based on
respectively MADRS- and BAI-scores.Cys Test-value p
73
29 (39.7) c2(1) ¼ 0.36 0.55
36.93 (9.87) t(126) ¼ 0.42 0.67
12.82 (2.89) t(126) ¼ 0.72 0.47
23/24/26 c2(2) ¼ 4.57 0.48
14/20/23/16 c2(3) ¼ 0.71 0.87
11.94 (9.75) t(124) ¼ 0.26 0.80
11.93 (10.56) t(126) ¼ 1.21 0.23
26 (35.6) c2(1) ¼ 2.86 0.09
ANX only MDD þ ANX Test-value p
28 37
8 (28.6) 13 (35.1) c2(3) ¼ 2.28 0.52
35.07 (7.84) 35.89 (11.57) F(3, 127) ¼ 0.93 0.43
12.46 (3.09) 12.49 (2.75) F(3, 127) ¼ 2.15 0.10
8/10/10 10/15/12 c2(6) ¼ 3.25 0.77
16 (57.1) 23 (62.1) c2(3) ¼ 0.71 0.87
13.14 (8.58) 17.68 (8.05) F(3, 125) ¼ 25.95 <0.001
15.68 (11) 18.35 (9.89) F(3, 127) ¼ 18.72 <0.001
9 (32.14) 19 (51.35) c2(2) ¼ 5.42 0.06
edical Center; UMCG: University Medical Center Groningen; HC: healthy controls;
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Regarding memory performance, neither genotype nor geno-
type by diagnosis interaction affected recognition accuracy (all
F < 2.19, p > 0.13) or RTs (All F < 2.40, p > 0.07; Supplement Table 1).
For visuospatial working memory (WM, Tower of London task),
a genotype by task load effect was observed on RTs over the whole
sample (see for statistics Fig. 1 and Supplement Table 1), indicating
a larger increase in RT from 4-steps to 5-steps in Ser-homozygotes
than Cys-carriers. Overall, no effect of diagnosis or interaction of
genotype and diagnosis was present on RTs (F < 0.38, p > 0.77). No
effects of genotype, diagnosis, nor interaction between genotype
and diagnosis were observed on planning accuracy (F < 1.37,
p > 0.26).
SSRI-use did not have an effect on proportion correct or RT
during both the memory- and the ToL-task.
3.3. Effect of Ser704Cys on the healthy brain
Differences in regional GM-volume were seen in the bilateral
parahippocampal gyrus (PHG) extending to the hippocampus. Cys-
carriers showed smaller volumes compared to Ser-homozygotes
(see Table 2 for statistics).
There were no effects of Ser704Cys on brain activation during
memory encoding or recognition. However, during visuospatial
WM, Cys-carriers showed less activation in the right dorsal ACC and
right DLPFC compared to Ser-homozygotes (Table 2, Fig. 2).
3.4. Effect of Ser704Cys on the brain of patients with affective
disorders
The effect of Ser704Cys genotype on (para)hippocampal volume
as seen in HC, was reversely observed within ANX: Cys-carriers
showed enlarged volume compared to Ser-homozygotes. In MDD
and CAD, there was no effect of genotype on hippocampal volumes.Table 2
Genotype effects of Ser704Cys on structural and functional data in our regions of interes
Region Side Direction of effect
Ser704Cys in HC
Structural
Parahippocampal gyrus/hippocampus R Ser/Ser > Cys
Parahippocampal gyrus/hippocampus L Ser/Ser > Cys
Tower of London
Anterior cingulate cortex (dorsal) R Ser/Ser > Cys
Dorsolateral prefrontal cortex R Ser/Ser > Cys
Ser704Cys in patients
Structural
Parahippocampal gyrus/hippocampus L ANX: Cys > Ser/Ser
Anterior cingulate cortex (rostral) L ANX: Cys > Ser/Ser
Dorsolateral prefrontal cortex R ANX: Cys > Ser/Ser
Dorsolateral prefrontal cortex L ANX: Cys > Ser/Ser
Memory encoding
Hippocampus R ANX: Cys > Ser/Ser (pos)
Tower of London
Anterior cingulate cortex (dorsal) L ANX: Cys > Ser/Ser
Dorsolateral prefrontal cortex L CAD: Ser/Ser > Cys
The post-hoc results are shown in this table. Results were regarded signiﬁcant at p < 0.05
there was no main effect of genotype on total grey matter (GM) volume (F(1,117) ¼ 0.13,
volume (F(3,117) ¼ 3.58, p¼ 0.02), corrected for age, sex and medication. Post-hoc t-tests
Ser-homozygotes (t ¼ 2.77, p ¼ 0.01), whereas no effect of genotype was observed withi
genotype subgroups differed on this variable by subtracting the mean GM total volume
The results for the memory encoding were speciﬁc for positive words (pos). The results
ANX ¼ anxiety group; CAD ¼ comorbidity anxiety and depression group.
a The number of voxels of the entire clusters at p < 0.001 uncorrected.
b The p-value reported is the peak voxel of the cluster. A threshold was set at p < 0.05
interest (ROI), with the initial voxel-wise height threshold set at Z > 3.In addition, within ANX, Ser704Cys had also an inﬂuence on ACC
and DLPFC volume: ANXCys-carriers had larger volumes compared
to Ser-homozygotes. These effects were absent in HC. Formal in-
teractions of genotype and diagnosis on regional GM volumes
conﬁrmed the speciﬁcity of genotype effects for HC and ANX in the
bilateral PHG/hippocampus (left F ¼ 10.94; right F ¼ 9.54), and for
ANX in the ACC (F ¼ 9.20), and bilateral DLPFC (left F ¼ 6.78; right
F ¼ 9.73).
Although in HC no effect of Ser704Cys was seen on activation
during memory processing, ANX Cys-carriers showed increased
right hippocampal activation compared with Ser-homozygotes
during encoding of positive words (Table 2). No such effects were
observed during encoding of negative words, nor in the other
groups. A formal interaction of genotype by diagnosis by valence
was observed in the right hippocampus during memory encoding
(F ¼ 6.01). During recognition, there was no effect of genotype in
the patient groups.
During visuospatial WM, within ANX an opposite pattern of
genotype was observed. In the dorsal ACC, ANX Cys-carriers
showed greater activation than Ser-homozygotes. There was no
effect of genotype in MDD and CAD patients. In contrast to HC, in
the right DLPFC there was no effect of genotype in patients,
whereas in the left DLPFC only in CAD an effect of genotype on
activation was seen (i.e. Cys < Ser) and not in controls, MDD, and
ANX. These effects were conﬁrmed in a formal interaction between
diagnosis and genotype (ACC F ¼ 8.88; left DLPFC F ¼ 6.99; right
DLPFC F ¼ 7.00).
Effects were unaffected by age, sex, education, scanning center,
medication use, depression/anxiety severity, grey matter volumes
or RTs.
4. Discussion
To our knowledge, this is the ﬁrst study that investigated effects
of DISC1-genotype on structure and function during botht.
MNI coordinates Ka t PFWEb Cohen's d
x y z
28 1 30 373 4.32 0.009 0.79
29 6 18 245 4.02 0.024 0.73
6 21 39 16 3.81 .042 0.70
33 42 30 20 4.00 0.036 0.73
26 24 7 919 4.46 0.005 0.82
11 51 3 288 5.64 <0.001 1.03
44 43 31 75 4.32 0.012 0.79
41 25 33 161 4.13 0.023 0.76
24 39 3 18 4.19 0.014 0.54
3 24 39 45 4.13 0.015 0.75
48 36 18 33 3.94 0.044 0.72
FWE corrected for the spatial extent for the region of interest. For the structural data,
p ¼ 0.72) observed, but a genotype by diagnosis interaction was present for total GM
showed that only within ANX, Cys-carriers had higher total GM volume compared to
n controls, MDD, or CAD. For the analysis on regional GM we took into account that
of the subgroup.
for memory recognition were independent of diagnostic group or word valence.
family wise error (FWE) voxel-wise corrected for the spatial extent of the region-of-
Fig. 2. Effects of Ser704Cys genotype on brain volume (A) and function during ToL (B,C) in healthy participants. A.) Increased parahippocampal volume in Ser-homozygotes
compared to Cys-carriers in HC. B.) Increased anterior cingulate cortex (ACC) and right dorsolateral prefrontal cortex (DLPFC) activation in Ser-homozygotes in HC. All depicted
at a threshold of p < 0.001.
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consisting of participants with and without current affective psy-
chopathology. Consistent with the literature, we found in healthy
participants an inﬂuence of Ser704Cys on hippocampal and PFC
morphology: the Cys-allele was associated with lower volume. In
addition, Cys-carriers showed less activation during spatial work-
ing memory (WM) in the dorsal ACC, and dorsal PFC. These effects
were reversed in patients with an anxiety disorders, whereas there
was no effect of genotype in patients with depression. During
episodic memory processing, there was no effect of genotype in
healthy participants, but there was an association in anxiety pa-
tients. This might suggest that presence of psychopathology mod-
erates Ser704Cys effects.4.1. Effect of Ser704Cys on the healthy brain
In agreement with a previous report (Di Giorgio et al., 2008), we
demonstrated that healthy Cys-carriers had smaller para-
hippocampal gyrus (PHG) and hippocampal volume than healthy
Ser-homozygotes. The PHG has an important role in episodic
memory (de Curtis and Pare. 2004; Eichenbaum et al., 2007).
Additionally, the PHG, together with the hippocampus, is involved
in processing of emotional (Drevets et al., 2008; Iidaka et al., 2001)
and visuospatial information (de Curtis and Pare. 2004). This
Ser704Cys-related difference in PHG and hippocampal volumemay
thus affect memory, visuospatial and emotion processing abilities,
at least within healthy people. Studies in DISC1-mutant mice have
shown decreased neurogenesis, neuronal migration and an in-
crease in depressive- and anxiety-like behavior (Clapcote et al.,
2007; Haque et al., 2012; Lee et al., 2011). Notably, smaller PHG
volumes have been found in anxiety disorders (Massana et al.,
2003; Liao et al., 2011) and depression (Abe et al., 2010; Kempton
et al., 2011). It has been proposed that volume reductions of hip-
pocampal areas in depression are related to stress and related
glucocorticoid levels (Bremner. 2006; Lee et al., 2002; Tata and
Anderson. 2010). Based on our results, it could be proposed that
reduced hippocampal volume related to carrying the Cys-‘risk’-
allele might also predispose to vulnerability for these disorders.During visuospatial WM, healthy Cys-carriers showed less
activation in the ACC and DLPFC with increasing planning load
compared to healthy Ser-homozygotes. Less DLPFC activation in
Cys-carriers has been shown for other executive processes as well
(Prata et al., 2008), but this is the ﬁrst study that showed genotype-
related variation in DLPFC activation speciﬁcally during visuospa-
tial WM. Decreased functionality of the DLPFC has been suggested
to lead to a reduction in control over the emotional state and less
ﬂexibility in diverging attention (Phillips et al., 2003), which may
increase vulnerability for developing an affective disorder. Indeed,
affective disorders have been associated with less DLPFC activation
during executive functioning (Goethals et al., 2005; Elliott et al.,
1997), although not consistently (Fitzgerald et al., 2008; Van Tol
et al., 2011).
In contrast to previous studies (Callicott et al., 2005; Di Giorgio
et al., 2008), we did not ﬁnd an inﬂuence of Ser704Cys on hippo-
campal activation during episodic memory in healthy participants.
This is to our knowledge the ﬁrst study investigating the inﬂuence
of Ser704Cys on brain activation on different tasks within the same
sample. Therefore, based on our ﬁndings it might be suggested that
DISC1-genotype has a larger effect on WM than on memory func-
tioning. Another possible explanation could be that the memory
task used in this study relied largely on emotional processing and
the effects of DISC1 have been suggested to be associated with
more cognitive functioning (Porteous et al., 2006).
4.2. Effect of Ser704Cys on the brain of patients with an affective
disorder
A noteworthy ﬁnding in our study was that presence of an af-
fective disorder moderated the effect of Ser704Cys on brain struc-
ture and function. Previous neuroimaging studies have also shown
moderating effects of psychiatric diagnoses on the inﬂuence of
genotype on the brain (Mechelli et al., 2008; Prata et al., 2009,
2011). This could be related to other factors inﬂuencing brain
physiology, including SSRI use, other genes (e.g. brain-derived
neurotrophic factor [BDNF](Molendijk et al., 2012), depressive
state (Van Tol et al., 2011), or epigenetic inﬂuences (Mechelli et al.,
2008)). However, previous studies by our group have shown no
E.M. Opmeer et al. / Journal of Psychiatric Research 61 (2015) 150e157156effects of SSRI use in this sample on brain morphology or activation
during visuospatial or memory processing (Van Tol et al., 2012; Van
Tol et al., 2011; Van Tol et al., 2010). Moreover, evidence from ani-
mal studies has shown that SSRI use might only affect neurogenesis
in youth, not in adulthood (Couillard-Despres et al., 2009; Navailles
et al., 2008). In addition, we controlled for SSRI use and depressive
state in the current analyses. A recent animal study has shown that
DISC1-mutations are leading to anxiety-like behavior only in the
context of stress (Haque et al., 2012), which could suggest epige-
netic inﬂuences. Moreover, for other genes it has also been
demonstrated in humans that depressed patients could be distin-
guished from healthy people based on methylation proﬁle
(Dempster et al., 2011; Fuchikami et al., 2011). Future research
should test whether stress might inﬂuence DISC1 expression via
epigenetic inﬂuences.
4.3. Strengths and limitations
To our knowledge, this is the ﬁrst study investigating the effect
of Ser704Cys on brain activation during multiple tasks and on brain
structure in participants both with and without depression and/or
psychopathology. Despite this strength, some limitations have to be
taken into account. First, the subgroups had a relatively small
sample size, although with expected genotype proportions. We
chose to only include participants who completed both tasks and
had high-quality structural data in order to end up with the same
sample for the three analyses. This approach was chosen to allow
proper comparisons of genetic ﬁndings between the different tasks
and to exclude the possible differences attributed to a different
sample. The relatively small sample size could have inﬂuenced the
unexpectedly large genotype differences in the anxiety group on
regional volume differences. Therefore, caution must be taken in
interpreting these results. However, the associations for genotype
were very consistent within controls, which bolsters conﬁdence
that reliable conclusions regarding a differential genotype effect
related to diagnosis can be reached. Second, there were many
variables in our sample that could have been confounding factors
(e.g. medication use, scanner site). For all identiﬁed effects, we have
tested for a possible inﬂuence of these confounding factors. Despite
not ﬁnding any inﬂuence of these possible confounders, such ef-
fects cannot be fully discarded. Third, the DISC1-gene is a complex
because there are haplotypes on this gene, including the Ser704Cys
SNP, inﬂuencing brain structure and activation during memory and
executive processing (Callicott et al., 2005; Palo et al., 2007). In
addition, DISC1 interacts with other proteins and therefore other
genes inﬂuence the effects of the DISC1-gene on cognitive func-
tioning (Duff et al., 2013; Rampino et al., 2014). These effects could
pose challenges to accurately model the effect of the Ser704Cys
SNP.
4.4. Conclusion
In conclusion, we show that DISC1 moderates regional brain
volumes in paralimbic structures crucial for emotional encoding
and activation in dorsal frontal structures crucial for executive
functioning, partially dependent on affective psychopathology. Our
results indicate the Cys-allele of the Ser704Cys SNP inﬂuences
endophenotypes relevant for affective disorders, although overt
psychopathology may affect this inﬂuence. Replication of these
ﬁndings is needed.
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